BACKGROUND: Primary hyperaldosteronism (Conn's syndrome) is being diagnosed increasingly often. As many as 12% of patients with hypertension have the characteristic laboratory constellation of Conn's syndrome. Its diagnosis and treatment have not been standardized. METHODS: The authors retrospectively analyzed data of 555 patients (327 men and 228 women, aged 55 +/- 13 years) who were treated for primary hyperaldosteronism in 5 different centers from 1990 to 2006. The objective was to determine center-specific features of diagnosis and treatment. RESULTS: 353 (63%) of the patients had the hypokalemic variant of primary hyperaldosteronism; 202 never had documented hypokalemia. The centers differed markedly with respect to the patients' clinical presentation, diagnostic testing of endocrine function, and diagnostic imaging techniques, including adrenal venous sampling. The adrenalectomy rate ranged from 15% to 46%. CONCLUSIONS: The registry data reveal an unexpected heterogeneity in the diagnostic evaluation and treatment of primary hyperaldosteronism. National or international guidelines are needed so that these can be standardized.
BACKGROUND:Primary hyperaldosteronism (Conn's syndrome) is being diagnosed increasingly often. As many as 12% of patients with hypertension have the characteristic laboratory constellation of Conn's syndrome. Its diagnosis and treatment have not been standardized. METHODS: The authors retrospectively analyzed data of 555 patients (327 men and 228 women, aged 55 +/- 13 years) who were treated for primary hyperaldosteronism in 5 different centers from 1990 to 2006. The objective was to determine center-specific features of diagnosis and treatment. RESULTS: 353 (63%) of the patients had the hypokalemic variant of primary hyperaldosteronism; 202 never had documented hypokalemia. The centers differed markedly with respect to the patients' clinical presentation, diagnostic testing of endocrine function, and diagnostic imaging techniques, including adrenal venous sampling. The adrenalectomy rate ranged from 15% to 46%. CONCLUSIONS: The registry data reveal an unexpected heterogeneity in the diagnostic evaluation and treatment of primary hyperaldosteronism. National or international guidelines are needed so that these can be standardized.
Authors: M Stowasser; R D Gordon; J C Rutherford; N Z Nikwan; N Daunt; G J Slater Journal: J Renin Angiotensin Aldosterone Syst Date: 2001-09 Impact factor: 1.636
Authors: J L Phillips; M M Walther; J C Pezzullo; W Rayford; P L Choyke; A A Berman; W M Linehan; J L Doppman; J R Gill Journal: J Clin Endocrinol Metab Date: 2000-12 Impact factor: 5.958
Authors: C E Fardella; L Mosso; C Gómez-Sánchez; P Cortés; J Soto; L Gómez; M Pinto; A Huete; E Oestreicher; A Foradori; J Montero Journal: J Clin Endocrinol Metab Date: 2000-05 Impact factor: 5.958
Authors: Michael Stowasser; Richard D Gordon; Thanuja G Gunasekera; Diane C Cowley; Gregory Ward; Colin Archibald; B Mark Smithers Journal: J Hypertens Date: 2003-11 Impact factor: 4.844
Authors: Paolo Mulatero; Michael Stowasser; Keh-Chuan Loh; Carlos E Fardella; Richard D Gordon; Lorena Mosso; Celso E Gomez-Sanchez; Franco Veglio; William F Young Journal: J Clin Endocrinol Metab Date: 2004-03 Impact factor: 5.958
Authors: Katharina Wolf-Maier; Richard S Cooper; José R Banegas; Simona Giampaoli; Hans-Werner Hense; Michel Joffres; Mika Kastarinen; Neil Poulter; Paola Primatesta; Fernando Rodríguez-Artalejo; Birgitta Stegmayr; Michael Thamm; Jaakko Tuomilehto; Diego Vanuzzo; Fenicia Vescio Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: Christoph Degenhart; Hanna Strube; Matthias J Betz; Anna Pallauf; Martin Bidlingmaier; Evelyn Fischer; Martin Reincke; Maximilian F Reiser; Stefan Wirth Journal: Diagn Interv Radiol Date: 2015 Jan-Feb Impact factor: 2.630
Authors: Jean Sossa; Dedjinnin Josue Georges Avakoudjo; Dodji Magloire Ines Yevi; Lionelle Fanou; Gilles Natchagande; Michel Michael Agounkpe; Fred Hodonou; Yao Felicien Hounto; Felix Atadokpede Journal: Case Rep Urol Date: 2021-05-10
Authors: Ammar Sarwar; Olga R Brook; Anand Vaidya; Ari C Sacks; Barry A Sacks; S Nahum Goldberg; Muneeb Ahmed; Salomao Faintuch Journal: J Vasc Interv Radiol Date: 2016-05-27 Impact factor: 3.464
Authors: Bertil Ekman; David Fitts; Claudio Marelli; Robert D Murray; Marcus Quinkler; Pierre M J Zelissen Journal: BMC Endocr Disord Date: 2014-05-09 Impact factor: 2.763